Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Other(1)

Detailed Status

Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
unknown133%

Recent Activity

0 active trials
Showing 3 of 3
unknownnot_applicable

Treating Emotional Processing Impairments in Individuals With TBI

NCT03373331
completednot_applicable

Remediation of Emotional Processing Deficits in MS

NCT03373344
completednot_applicable

Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury

NCT04408274

Clinical Trials (3)

Showing 3 of 3 trials
NCT03373331Not Applicable

Treating Emotional Processing Impairments in Individuals With TBI

Unknown
NCT03373344Not Applicable

Remediation of Emotional Processing Deficits in MS

Completed
NCT04408274Not Applicable

Remediation of Emotional Deficits in Multiple Sclerosis and Traumatic Brain Injury

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3